Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Michael Gaynon M.D., Palo Alto Medical Foundation
ClinicalTrials.gov Identifier:
NCT00493064
First received: June 25, 2007
Last updated: October 21, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)